The TPO receptor has been proposed to exist as an inactive preformed dimer (left side) with a proximal and distal hematopoietic receptor domain (HRD) (HRD-1 and HRD-2, respectively). Upon binding of TPO to the distal HRD-2, the conformation of the receptor changes (right side) and a number of signal transduction pathways are activated that increase platelet production.
TPO: thrombopoietin; HRD: hematopoietic receptor domain protein; STAT: signal transducer and activator of transcription; JAK: Janus kinase; GRP2: growth receptor bound protein 2; SOS: guanine nucleotide exchange factor; RAS: GTP-ase; RAF: serine-threonine kinase; MAPK: mitogen-activated protein kinase (also a serine-threonine kinase).